Non-Small Cell Lung Cancer Latest Advances

Customize your search results with filters

Term Search

You can select from the dropdown list OR enter your own terms to refine the search.

Save publications for later

Not sure about your diagnosis?

Check Your Symptoms

Found 1427 publications

The efficacy of immune checkpoint inhibitors in thoracic malignancies.

Condition: Thoracic Malignancies

Journal: European respiratory review : an official journal of the European Respiratory Society

Treatment Used: Immune Checkpoint Inhibitors (ICIs)

Published: October 07, 2021

View publication

Summary: This article discusses the effectiveness of immune checkpoint inhibitors (ICIs) in the treatment of patients with thoracic malignancies.

Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report.

Condition: Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal: The Journal of international medical research

Treatment Used: Toripalimab

Number of Patients: 1

Published: October 04, 2021

View publication

Summary: This case report describes a 61-year-old man diagnosed with advanced non-small cell lung cancer (NSCLC) in poor condition treated with toripalimab.

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.

Condition: Non-Small Cell Lung Cancer (NSCLC)

Journal: BMC pulmonary medicine

Treatment Used: Immune Checkpoint Inhibitors (ICIs)

Number of Patients: 175

Published: October 03, 2021

View publication

Summary: This study determined the effectiveness of checkpoint inhibitors (ICIs) for the treatment of patients with non-small cell lung cancer (NSCLC) with uncommon histology (uNSCLC).

Successful treatment with lorlatinib in a patient with meningeal carcinomatosis of ALK-positive non-small cell lung cancer resistant to alectinib and brigatinib: A case report.

Condition: Meningeal Carcinomatosis of ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal: Medicine

Treatment Used: Lorlatinib

Number of Patients: 1

Published: October 01, 2021

View publication

Summary: This case report describes a 55-year-old woman diagnosed with meningeal carcinomatosis of ALK-positive non-small cell lung cancer (NSCLC) resistant to alectinib and brigatinib treated with lorlatinib.

Pralsetinib for the treatment of non-small cell lung cancer.

Condition: Non-Small Cell Lung Cancer (NSCLC)

Journal: Drugs of today (Barcelona, Spain : 1998)

Treatment Used: Pralsetinib

Published: September 29, 2021

View publication

Summary: This article discusses the use of pralsetinib in the treatment of patients with non-small cell lung cancer (NSCLC).

Application of immune checkpoint inhibitors in colorectal cancer.

Condition: Colorectal Cancer (CRC)

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Treatment Used: Immune Checkpoint Inhibitors (ICIs)

Published: September 27, 2021

View publication

Summary: This article discusses the use of immune checkpoint inhibitors (ICIs) in the treatment of patients with colorectal cancer (CRC).

Short- and medium-term outcomes after uniportal and multiportal video-assisted thoracic surgery lobectomy in elderly patients with non-small cell lung cancer.

Condition: Elderly Patients with Non-Small Cell Lung Cancer (NSCLC)

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Treatment Used: Uniportal vs. Multiportal Video-Assisted Thoracic Surgery (VATS) Lobectomy

Number of Patients: 74

Published: September 26, 2021

View publication

Summary: This study investigated the outcomes of uniportal versus multiportal video-assisted thoracic surgery (VATS) lobectomy in the treatment of elderly patients with non-small cell lung cancer (NSCLC).

Upfront thoracic radiotherapy to primary lesion improves outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations.

Condition: Stage IV Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Treatment Used: Thoracic Radiotherapy

Number of Patients: 141

Published: September 26, 2021

View publication

Summary: This study examined the effectiveness of upfront thoracic radiotherapy in the treatment of patients with stage IV non-small cell lung cancer (NSCLC) harboring EGFR mutations.

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC.

Condition: Previously Untreated, EGFR Mutation-Positive, Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal: Targeted oncology

Treatment Used: Osimertinib

Published: September 26, 2021

View publication

Summary: This review of the literature summarized the use of osimertinib in the treatment of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data.

Condition: Older Japanese Patients with Lung Cancer

Journal: PloS one

Treatment Used: First-Line Treatment

Number of Patients: 9737

Published: September 20, 2021

View publication

Summary: This study reported first-line treatment for older Japanese patients with advanced non-small cell lung cancer (NSCLC).

Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial.

Condition: Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal: Radiation oncology (London, England)

Treatment Used: Sintilimab, Stereotactic Body Radiotherapy (SBRT), and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) as Second-Line Therapy

Number of Patients: 20

Published: September 16, 2021

View publication

Summary: This study determined the tolerability and safety of sintilimab, stereotactic body radiotherapy (SBRT) and granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of patients with advanced non-small cell lung cancer (NSCLC).

Pulmonary function after segmentectomy versus lobectomy in patients with early-stage non-small-cell lung cancer: a meta-analysis.

Condition: Early-Stage Non-Small-Cell Lung Cancer (NSCLC)

Journal: The Journal of international medical research

Treatment Used: Segmentectomy vs. Lobectomy

Number of Patients: 2027

Published: September 15, 2021

View publication

Summary: This review of the literature compared segmentectomy versus lobectomy in the treatment of patients with early-stage non-small-cell lung cancer (NSCLC).

Showing 1-12 of 1427